A case of Andersen-Tawil syndrome presenting periodic paralysis exacerbated by acetazolamide

J Neurol Sci. 2014 Dec 15;347(1-2):385-6. doi: 10.1016/j.jns.2014.09.040. Epub 2014 Sep 30.

Authors

Satoshi Nagamine¹, Shunichi Sakoda², Reiji Koide³, Akihiro Kawata³, Junhui Yuan², Hiroshi Takashima², Imaharu Nakano³

Affiliations

¹ Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan. Electronic address: [email protected].
² Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
³ Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.

PMID: 25284084
DOI: 10.1016/j.jns.2014.09.040

No abstract available

Keywords: Acetazolamide; Andersen–Tawil syndrome; Hypokalemic; KCNJ2; Periodic paralysis; SCN4A.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acetazolamide / adverse effects*
Adult
Andersen Syndrome / drug therapy*
Anticonvulsants / adverse effects*
Humans
Male
Paralysis / chemically induced*

Substances

Anticonvulsants
Acetazolamide